GSK lifts long-term outlook following launch of blockbuster vaccine in 2023

The FTSE-100 drugmaker predicted new drug and vaccine launches will see its annual sales hit £38 billion by 2031

Related Keywords

London ,City Of ,United Kingdom ,British ,Emma Walmsley ,Drug Administration ,Article Normal ,Pharmaceuticals ,Vaccines ,Scientific Research Services ,Health Care ,Business Consumer Services ,Specialized Drugs Medications ,Medical Research Services ,Drug Discovery Development ,Healthcare Support Services ,Diagnostic Medical Research Services ,Financial Performance ,Earnings ,Sales Figures ,New Products Services ,Corporate Industrial News ,Products Services ,Political General News ,Health ,Immunizations ,Medical Treatments Procedures ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Gsk Plc ,Uk Gsk ,New Products ,Services ,Corporate ,Industrial News ,Products ,Political ,General News ,Medical Treatments ,Procedures ,Business ,Consumer Services ,Specialized Drugs ,Medications ,Drug Discovery ,Development ,Diagnostic ,